Komori
ASKA Pharmaceutical Holdings (4886) · TargetFirst stated

女性医療による社会的インパクトの可視化

First written in 2026-10-01. . Latest entry: 2026-10-01.

1entries
1years
1from disclosures
Share on X
How it moved
Same theme, other companies

This thread is not in a theme yet. When the same subject shows up in other companies' filings, you can compare them here.

Full recordFilings, disclosures and news, newest first
  1. 2026-10-01First statedGovernance

    「当社グループでは、経済産業省が公表した「女性特有の健康課題による経済損失の試算と健康経営の必要性について」を参考に、女性の健康課題が社会や経済活動に与える影響に着目しています。」

    2025年度の女性医療に関する社会的インパクトを907億円と推計し、医薬品による551億円と疾患啓発による356億円の経済損失軽減額を示している。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview It last moved in the Governance of 2026-10-01: "First stated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.